Showing results (681-690 of 971) with videos related to
Sort By:
Pageof 98
Journal of the National Cancer Institute|April 22, 2026
Premenopausal and postmenopausal obesity and endometrial cancer risk: circulating biomarkers of inflammation, insulin resistance, and sex hormones as mediatorsSabrina E Wang, Vivian Viallon, Carine Biessy, et al.BMC Cancer|October 24, 2018
Receptor activator of nuclear factor kB ligand, osteoprotegerin, and risk of death following a breast cancer diagnosis: results from the EPIC cohortDanja Sarink, Helena Schock, Theron Johnson, et al.The Lancet. Oncology|July 30, 2013
Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies, T J Key, P N Appleby, et al.European Journal of Nutrition|February 7, 2016
Dietary and lifestyle determinants of acrylamide and glycidamide hemoglobin adducts in non-smoking postmenopausal women from the EPIC cohortMireia Obón-Santacana, Leila Lujan-Barroso, Heinz Freisling, et al.Environmental Science & Technology|October 24, 2023
Impact of Biomass Burning Organic Aerosol Volatility on Smoke Concentrations Downwind of FiresDemetrios Pagonis, Vanessa Selimovic, Pedro Campuzano-Jost, et al.Journal of the National Cancer Institute|June 4, 2018
Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort ConsortiumBritton Trabert, Elizabeth M Poole, Emily White, et al.International Journal of Cancer|April 2, 2025
Education level and risk of breast cancer by tumor subtype in the EPIC cohortMargherita Pizzato, Valerie McCormack, Laure Dossus, et al.JNCI Cancer Spectrum|November 22, 2021
Endogenous Circulating Sex Hormone Concentrations and Colon Cancer Risk in Postmenopausal Women: A Prospective Study and Meta-AnalysisNagisa Mori, Pekka Keski-Rahkonen, Audrey Gicquiau, et al.BMC Medicine|April 18, 2022
Circulating inflammatory biomarkers, adipokines and breast cancer risk-a case-control study nested within the EPIC cohortManon Cairat, Sabina Rinaldi, Anne-Sophie Navionis, et al.Breast Cancer Research : BCR|December 5, 2018
Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohortsKuanrong Li, Garnet Anderson, Vivian Viallon, et al.Pageof 98